Karl-Erik Andersson to Male
This is a "connection" page, showing publications Karl-Erik Andersson has written about Male.
Connection Strength
1.858
-
Andersson KE, Longstreth J, Brucker BM, Campeau L, Cheng L, Francis L, Fein S. Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects. Pharm Res. 2019 Apr 29; 36(6):92.
Score: 0.043
-
Andersson KE, Van Kerrebroeck P. Pharmacotherapy for Nocturia. Curr Urol Rep. 2018 Feb 09; 19(1):8.
Score: 0.040
-
Simonsen U, Comerma-Steffensen S, Andersson KE. Modulation of Dopaminergic Pathways to Treat Erectile Dysfunction. Basic Clin Pharmacol Toxicol. 2016 Oct; 119 Suppl 3:63-74.
Score: 0.036
-
Andersson KE. Potential Future Pharmacological Treatment of Bladder Dysfunction. Basic Clin Pharmacol Toxicol. 2016 Oct; 119 Suppl 3:75-85.
Score: 0.035
-
Sawada N, Nomiya M, Zarifpour M, Mitsui T, Takeda M, Andersson KE. Melatonin Improves Erectile Function in Rats With Chronic Lower Body Ischemia. J Sex Med. 2016 Feb; 13(2):179-86.
Score: 0.034
-
Andersson KE. Mechanisms of ATP release--future therapeutic targets? BJU Int. 2015 Jun; 115(6):850-1.
Score: 0.033
-
Andersson KE. Intraprostatic injections for lower urinary tract symptoms treatment. Curr Opin Urol. 2015 Jan; 25(1):12-8.
Score: 0.032
-
Andersson KE. The use of pharmacotherapy for male patients with urgency and stress incontinence. Curr Opin Urol. 2014 Nov; 24(6):571-7.
Score: 0.032
-
Zarifpour M, Nomiya M, Sawada N, Andersson KE. Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia. Prostate. 2015 Feb 15; 75(3):233-41.
Score: 0.032
-
Yamaguchi O, Nomiya M, Andersson KE. Functional consequences of chronic bladder ischemia. Neurourol Urodyn. 2014 Jan; 33(1):54-8.
Score: 0.030
-
Andersson KE. Bladder underactivity. Eur Urol. 2014 Feb; 65(2):399-401.
Score: 0.030
-
Nomiya M, Yamaguchi O, Akaihata H, Hata J, Sawada N, Kojima Y, Andersson KE. Progressive vascular damage may lead to bladder underactivity in rats. J Urol. 2014 May; 191(5):1462-9.
Score: 0.030
-
Sawada N, Nomiya M, Hood B, Koslov D, Zarifpour M, Andersson KE. Protective effect of a ß3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia. Eur Urol. 2013 Oct; 64(4):664-71.
Score: 0.029
-
Nomiya M, Burmeister DM, Sawada N, Campeau L, Zarifpour M, Yamaguchi O, Andersson KE. Effect of melatonin on chronic bladder-ischaemia-associated changes in rat bladder function. BJU Int. 2013 Jul; 112(2):E221-30.
Score: 0.028
-
Andersson KE. Treatment of lower urinary tract symptoms: agents for intraprostatic injection. Scand J Urol. 2013 Apr; 47(2):83-90.
Score: 0.028
-
Ishizuka O, Imamura T, Kurizaki Y, Nishizawa O, Andersson KE. Male lower urinary tract symptoms and a1D-adrenoceptors. Int J Urol. 2013 Jan; 20(1):73-8.
Score: 0.028
-
Nomiya M, Burmeister DM, Sawada N, Campeau L, Zarifpour M, Keys T, Peyton C, Yamaguchi O, Andersson KE. Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia. J Urol. 2013 Feb; 189(2):754-61.
Score: 0.027
-
Gratzke C, Andersson KE. a-Blockers and antimuscarinics for male lower urinary tract symptoms: the search goes on. Eur Urol. 2013 Jan; 63(1):166-7; discussion 168.
Score: 0.027
-
Andersson KE. Drugs for lower urinary tract symptoms--anything new? J Urol. 2012 Aug; 188(2):349-50.
Score: 0.027
-
Kurizaki Y, Ishizuka O, Imamura T, Ishikawa M, Ichino M, Ogawa T, Nishizawa O, Andersson KE. Relationship between expression of ß3-adrenoceptor mRNA in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Neurourol Urodyn. 2013 Jan; 32(1):88-91.
Score: 0.027
-
Andersson KE, Abdel-Hamid IA. Therapeutic targets for premature ejaculation. Maturitas. 2011 Sep; 70(1):26-33.
Score: 0.025
-
Asche CV, Kim J, Kulkarni AS, Chakravarti P, Andersson KE. Presence of central nervous system, cardiovascular and overall co-morbidity burden in patients with overactive bladder disorder in a real-world setting. BJU Int. 2012 Feb; 109(4):572-80.
Score: 0.025
-
Füllhase C, Soler R, Westerling-Andersson K, Andersson KE. Beta3-adrenoceptors in the rat sacral spinal cord and their functional relevance in micturition under normal conditions and in a model of partial urethral obstruction. Neurourol Urodyn. 2011 Sep; 30(7):1382-7.
Score: 0.025
-
Andersson KE, Soler R, Füllhase C. Rodent models for urodynamic investigation. Neurourol Urodyn. 2011 Jun; 30(5):636-46.
Score: 0.025
-
Andersson KE, de Groat WC, McVary KT, Lue TF, Maggi M, Roehrborn CG, Wyndaele JJ, Melby T, Viktrup L. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn. 2011 Mar; 30(3):292-301.
Score: 0.024
-
Streng T, Santti R, Andersson KE. Voiding effects mediated by a2-adrenoceptors in the anaesthetized male rat. BJU Int. 2010 Nov; 106(10):1546-9.
Score: 0.024
-
Kurizaki Y, Ishizuka O, Imamura T, Ichino M, Ogawa T, Igawa Y, Nishizawa O, Andersson KE. Relation between expression of a(1)-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2011 Feb; 45(1):15-9.
Score: 0.024
-
Füllhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE. Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction. J Urol. 2010 Aug; 184(2):783-9.
Score: 0.023
-
Soler R, Füllhase C, Lu B, Bishop CE, Andersson KE. Bladder dysfunction in a new mutant mouse model with increased superoxide--lack of nitric oxide? J Urol. 2010 Feb; 183(2):780-5.
Score: 0.023
-
Andersson KE, Sarawate C, Kahler KH, Stanley EL, Kulkarni AS. Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder. BJU Int. 2010 Jul; 106(2):268-74.
Score: 0.022
-
Füllhase C, Soler R, Gratzke C, Brodsky M, Christ GJ, Andersson KE. Urodynamic evaluation of fesoterodine metabolite, doxazosin and their combination in a rat model of partial urethral obstruction. BJU Int. 2010 Jul; 106(2):287-93.
Score: 0.022
-
Abdel-Hamid IA, Andersson KE. Pharmacogenetics and pharmacogenomics of sexual dysfunction: current status, gaps and potential applications. Pharmacogenomics. 2009 Oct; 10(10):1625-44.
Score: 0.022
-
Roosen A, Chapple CR, Dmochowski RR, Fowler CJ, Gratzke C, Roehrborn CG, Stief CG, Andersson KE. A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol. 2009 Nov; 56(5):810-9.
Score: 0.022
-
Gratzke C, Streng T, Park A, Christ G, Stief CG, Hedlund P, Andersson KE. Distribution and function of cannabinoid receptors 1 and 2 in the rat, monkey and human bladder. J Urol. 2009 Apr; 181(4):1939-48.
Score: 0.021
-
Abdel-Hamid IA, Jannini EA, Andersson KE. Premature ejaculation: focus on therapeutic targets. Expert Opin Ther Targets. 2009 Feb; 13(2):175-93.
Score: 0.021
-
Andersson KE. How many drugs for LUTS due to BPH are too many? J Urol. 2008 Sep; 180(3):811-2.
Score: 0.020
-
Aizawa N, Ishizuka O, Ogawa T, Mizusawa H, Igawa Y, Nishizawa O, Andersson KE. Effects of natriuretic peptides on intracavernous pressure and blood pressure in conscious rats. J Sex Med. 2008 Oct; 5(10):2312-7.
Score: 0.020
-
Abrams P, Andersson KE. Muscarinic receptor antagonists for overactive bladder. BJU Int. 2007 Nov; 100(5):987-1006.
Score: 0.019
-
Christ GJ, Andersson KE. Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Neurourol Urodyn. 2007 Oct; 26(6 Suppl):948-54.
Score: 0.019
-
Andersson KE, Uckert S, Stief C, Hedlund P. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Neurourol Urodyn. 2007 Oct; 26(6 Suppl):928-33.
Score: 0.019
-
Andersson KE, Gratzke C. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system. Nat Clin Pract Urol. 2007 Jul; 4(7):368-78.
Score: 0.019
-
Hedlund P, Streng T, Lee T, Andersson KE. Effects of tolterodine on afferent neurotransmission in normal and resiniferatoxin treated conscious rats. J Urol. 2007 Jul; 178(1):326-31.
Score: 0.019
-
Andersson KE, Mulhall JP, Wyllie MG. Pharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for 'on-demand' treatment of premature ejaculation. BJU Int. 2006 Feb; 97(2):311-5.
Score: 0.017
-
Andersson KE. Tachykinins: role in detrusor overactivity? Eur Urol. 2006 Mar; 49(3):423-5.
Score: 0.017
-
Hedlund P, Matsumoto K, Andersson KE. Animal models of erectile dysfunction. Curr Protoc Pharmacol. 2005 Jul; Chapter 5:Unit5.41.
Score: 0.017
-
Igawa Y, Zhang X, Nishizawa O, Umeda M, Iwata A, Taketo MM, Manabe T, Matsui M, Andersson KE. Cystometric findings in mice lacking muscarinic M2 or M3 receptors. J Urol. 2004 Dec; 172(6 Pt 1):2460-4.
Score: 0.016
-
Andersson KE. Storage and voiding symptoms: pathophysiologic aspects. Urology. 2003 Nov; 62(5 Suppl 2):3-10.
Score: 0.015
-
Andersson KE. Erectile physiological and pathophysiological pathways involved in erectile dysfunction. J Urol. 2003 Aug; 170(2 Pt 2):S6-13; discussion S13-4.
Score: 0.015
-
Mizusawa H, Hedlund P, Sjunnesson J, Brioni JD, Sullivan JP, Andersson KE. Enhancement of apomorphine-induced penile erection in the rat by a selective alpha(1D)-adrenoceptor antagonist. Br J Pharmacol. 2002 Jul; 136(5):701-8.
Score: 0.013
-
Andersson KE. Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists. World J Urol. 2002 Apr; 19(6):390-6.
Score: 0.013
-
Chapple C, Andersson KE. Tamsulosin: an overview. World J Urol. 2002 Apr; 19(6):397-404.
Score: 0.013
-
Andersson KE, Chapple CR, Höfner K. Future drugs for the treatment of benign prostatic hyperplasia. World J Urol. 2002 Apr; 19(6):436-42.
Score: 0.013
-
Mizusawa H, Hedlund P, Andersson KE. alpha-Melanocyte stimulating hormone and oxytocin induced penile erections, and intracavernous pressure increases in the rat. J Urol. 2002 Feb; 167(2 Pt 1):757-60.
Score: 0.013
-
Sievert KD, Hennenlotter J, Dillenburg T, Toomey P, Wöllner J, Zweers P, Pannek J, Andersson KE, Amend B. Extended periprostatic nerve distributions on the prostate surface confirmed using diffusion tensor imaging. BJU Int. 2019 06; 123(6):995-1004.
Score: 0.011
-
Kira S, Mitsui T, Miyamoto T, Ihara T, Nakagomi H, Hashimoto Y, Takamatsu H, Tanahashi M, Takeda M, Sawada N, Andersson KE, Takeda M. Liquid chromatography-mass spectrometry identification of serum biomarkers for nocturia in aged men. World J Urol. 2019 Oct; 37(10):2199-2205.
Score: 0.011
-
Lombardo R, Andersson KE, Tubaro A, De Nunzio C. Intraprostatic injections for lower urinary tract symptoms/benign prostatic enlargement treatment. Minerva Urol Nefrol. 2018 Dec; 70(6):570-578.
Score: 0.010
-
Zambon JP, Patel M, Hemal A, Badlani G, Andersson KE, Magalhaes RS, Lankford S, Dean A, Williams JK. Nonhuman primate model of persistent erectile and urinary dysfunction following radical prostatectomy: Feasibility of minimally invasive therapy. Neurourol Urodyn. 2018 09; 37(7):2141-2150.
Score: 0.010
-
Butler DSC, Ambite I, Nagy K, Cafaro C, Ahmed A, Nadeem A, Filenko N, Tran TH, Andersson KE, Wullt B, Puthia M, Svanborg C. Neuroepithelial control of mucosal inflammation in acute cystitis. Sci Rep. 2018 07 20; 8(1):11015.
Score: 0.010
-
Hämäläinen MD, Zetterström A, Winkvist M, Söderquist M, Karlberg E, Öhagen P, Andersson K, Nyberg F. Real-time Monitoring using a breathalyzer-based eHealth system can identify lapse/relapse patterns in alcohol use disorder Patients. Alcohol Alcohol. 2018 Jul 01; 53(4):368-375.
Score: 0.010
-
Eberli D, Horst M, Mortezavi A, Andersson KE, Gobet R, Sulser T, Simon HU, Salemi S. Increased autophagy contributes to impaired smooth muscle function in neurogenic lower urinary tract dysfunction. Neurourol Urodyn. 2018 11; 37(8):2414-2424.
Score: 0.010
-
De Nunzio C, Roehrborn CG, Andersson KE, McVary KT. Erectile Dysfunction and Lower Urinary Tract Symptoms. Eur Urol Focus. 2017 10; 3(4-5):352-363.
Score: 0.010
-
Jakobsen LK, Trelborg KF, Simonsen U, Andersson KE, Olsen LH. Development of contractile properties in the fetal porcine urinary bladder. Pediatr Res. 2018 01; 83(1-1):148-155.
Score: 0.010
-
Aizawa N, Ichihara K, Fukuhara H, Fujimura T, Andersson KE, Homma Y, Igawa Y. Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction. Sci Rep. 2017 08 09; 7(1):7646.
Score: 0.010
-
Mann-Gow TK, Larson TR, Wøien CT, Andersen TM, Andersson KE, Zvara P. Evaluating the Procedure for Performing Awake Cystometry in a Mouse Model. J Vis Exp. 2017 05 20; (123).
Score: 0.009
-
Riemsma R, Hagen S, Kirschner-Hermanns R, Norton C, Wijk H, Andersson KE, Chapple C, Spinks J, Wagg A, Hutt E, Misso K, Deshpande S, Kleijnen J, Milsom I. Can incontinence be cured? A systematic review of cure rates. BMC Med. 2017 03 24; 15(1):63.
Score: 0.009
-
Lin WY, Andersson KE, Lin CL, Kao CH, Wu HC. Association of lower urinary tract syndrome with peripheral arterial occlusive disease. PLoS One. 2017; 12(3):e0170288.
Score: 0.009
-
Ihara T, Mitsui T, Nakamura Y, Kira S, Nakagomi H, Sawada N, Hirayama Y, Shibata K, Shigetomi E, Shinozaki Y, Yoshiyama M, Andersson KE, Nakao A, Takeda M, Koizumi S. Clock Genes Regulate the Circadian Expression of Piezo1, TRPV4, Connexin26, and VNUT in an Ex Vivo Mouse Bladder Mucosa. PLoS One. 2017; 12(1):e0168234.
Score: 0.009
-
Hillerdal V, Boura VF, Björkelund H, Andersson K, Essand M. Avidity characterization of genetically engineered T-cells with novel and established approaches. BMC Immunol. 2016 07 13; 17(1):23.
Score: 0.009
-
Ihara T, Mitsui T, Nakamura Y, Kira S, Miyamoto T, Nakagomi H, Sawada N, Hirayama Y, Shibata K, Shigetomi E, Shinozaki Y, Yoshiyama M, Andersson KE, Nakao A, Takeda M, Koizumi S. The Clock mutant mouse is a novel experimental model for nocturia and nocturnal polyuria. Neurourol Urodyn. 2017 04; 36(4):1034-1038.
Score: 0.009
-
Ito H, Kamei J, Aizawa N, Fujita Y, Suzuki M, Fukuhara H, Fujimura T, Kojima T, Homma Y, Kubota Y, Ito M, Andersson KE, Igawa Y. Preventive Effects of Long-Term Caloric Restriction on Aging Related In Vivo Bladder Dysfunction and Molecular Biological Changes in the Bladder and Dorsal Root Ganglia in Rats. J Urol. 2016 11; 196(5):1575-1583.
Score: 0.009
-
Abdel-Hamid IA, Andersson KE, Waldinger MD, Anis TH. Tramadol Abuse and Sexual Function. Sex Med Rev. 2016 07; 4(3):235-246.
Score: 0.009
-
Gacci M, Andersson KE, Chapple C, Maggi M, Mirone V, Oelke M, Porst H, Roehrborn C, Stief C, Giuliano F. Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Eur Urol. 2016 07; 70(1):124-133.
Score: 0.009
-
Peng Z, Andersson K, Lindholm J, Dethlefsen O, Pramana S, Pawitan Y, Nistér M, Nilsson S, Li C. Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material. PLoS One. 2016; 11(1):e0145545.
Score: 0.009
-
Burmeister D, Bishwokarma B, AbouShwareb T, Olson J, Herco M, Tan J, Andersson KE, Christ G. The potential utility of non-invasive imaging to monitor restoration of bladder structure and function following subtotal cystectomy (STC). BMC Urol. 2015 Oct 14; 15:103.
Score: 0.008
-
Salemi S, Tremp M, Plock JA, Andersson KE, Gobet R, Sulser T, Eberli D. Differentiated adipose-derived stem cells for bladder bioengineering. Scand J Urol. 2015; 49(5):407-14.
Score: 0.008
-
Ito H, Aizawa N, Fujita Y, Suzuki M, Fukuhara H, Homma Y, Kubota Y, Ito M, Andersson KE, Igawa Y. Long-term caloric restriction in rats may prevent age related impairment of in vitro bladder function. J Urol. 2015 Jun; 193(6):2123-30.
Score: 0.008
-
Nomiya M, Andersson KE, Yamaguchi O. Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms. Int J Urol. 2015 Jan; 22(1):40-6.
Score: 0.008
-
Peng Z, Andersson K, Lindholm J, Bodin I, Pramana S, Pawitan Y, Nistér M, Nilsson S, Li C. Operator dependent choice of prostate cancer biopsy has limited impact on a gene signature analysis for the highly expressed genes IGFBP3 and F3 in prostate cancer epithelial cells. PLoS One. 2014; 9(10):e109610.
Score: 0.008
-
Kunit T, Gratzke C, Schreiber A, Strittmatter F, Waidelich R, Rutz B, Loidl W, Andersson KE, Stief CG, Hennenberg M. Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate. Am J Physiol Renal Physiol. 2014 Oct 01; 307(7):F823-32.
Score: 0.008
-
Aro E, Bastman S, Andersson KE, Streng T. Is there a peripheral site of action contributing to the voiding effects of a2-adrenoceptor agonists and antagonists? World J Urol. 2015 Mar; 33(3):433-40.
Score: 0.008
-
Birder LA, Andersson KE, Kanai AJ, Hanna-Mitchell AT, Fry CH. Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013. Neurourol Urodyn. 2014 Jun; 33(5):597-601.
Score: 0.008
-
Sunagawa M, Wolf-Johnston A, Nomiya M, Sawada N, Andersson KE, Hisamitsu T, Birder LA. Urinary bladder mucosal responses to ischemia. World J Urol. 2015 Feb; 33(2):275-80.
Score: 0.008
-
Dubois L, Andersson K, Asplund A, Björkelund H. Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods. BMC Res Notes. 2013 Dec 18; 6:542.
Score: 0.007
-
Tremp M, Salemi S, Largo R, Andersson KE, Plock JA, Plock J, Aboushwareb T, Sulser T, Eberli D. Adipose-derived stem cells (ADSCs) and muscle precursor cells (MPCs) for the treatment of bladder voiding dysfunction. World J Urol. 2014 Oct; 32(5):1241-8.
Score: 0.007
-
Hennenberg M, Miljak M, Herrmann D, Strittmatter F, Walther S, Rutz B, Hocaoglu Y, Kunit T, Schreiber A, Andersson KE, Stief CG, Gratzke C. The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle. Am J Physiol Renal Physiol. 2013 Nov 15; 305(10):F1383-90.
Score: 0.007
-
Soler R, Andersson KE, Chancellor MB, Chapple CR, de Groat WC, Drake MJ, Gratzke C, Lee R, Cruz F. Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms. Eur Urol. 2013 Oct; 64(4):610-21.
Score: 0.007
-
Füllhase C, Hennenberg M, Giese A, Schmidt M, Strittmatter F, Soler R, Gratzke C, Andersson KE, Stief C. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity. J Urol. 2013 Oct; 190(4):1430-5.
Score: 0.007
-
Altai M, Varasteh Z, Andersson K, Eek A, Boerman O, Orlova A. In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumors. Cancer Biother Radiopharm. 2013 Apr; 28(3):187-95.
Score: 0.007
-
Ko IK, Lee BK, Lee SJ, Andersson KE, Atala A, Yoo JJ. The effect of in vitro formation of acetylcholine receptor (AChR) clusters in engineered muscle fibers on subsequent innervation of constructs in vivo. Biomaterials. 2013 Apr; 34(13):3246-55.
Score: 0.007
-
Svalø J, Nordling J, Bouchelouche K, Andersson KE, Korstanje C, Bouchelouche P. The novel ß3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity. Eur J Pharmacol. 2013 Jan 15; 699(1-3):101-5.
Score: 0.007
-
Hennenberg M, Strittmatter F, Beckmann C, Rutz B, Füllhase C, Waidelich R, Montorsi F, Hedlund P, Andersson KE, Stief CG, Gratzke C. Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle. PLoS One. 2012; 7(11):e50904.
Score: 0.007
-
Orlova A, Hofström C, Strand J, Varasteh Z, Sandstrom M, Andersson K, Tolmachev V, Gräslund T. [99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours. Eur J Nucl Med Mol Imaging. 2013 Feb; 40(3):439-49.
Score: 0.007
-
Burmeister D, AbouShwareb T, D'Agostino R, Andersson KE, Christ GJ. Impact of partial urethral obstruction on bladder function: time-dependent changes and functional correlates of altered expression of Ca²? signaling regulators. Am J Physiol Renal Physiol. 2012 Jun 15; 302(12):F1517-28.
Score: 0.007
-
Nomiya M, Sagawa K, Yazaki J, Takahashi N, Kushida N, Haga N, Aikawa K, Matsui T, Oka M, Fukui T, Andersson KE, Yamaguchi O. Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia. Neurourol Urodyn. 2012 Jan; 31(1):185-9.
Score: 0.006
-
Nomiya M, Yamaguchi O, Andersson KE, Sagawa K, Aikawa K, Shishido K, Yanagida T, Kushida N, Yazaki J, Takahashi N. The effect of atherosclerosis-induced chronic bladder ischemia on bladder function in the rat. Neurourol Urodyn. 2012 Jan; 31(1):195-200.
Score: 0.006
-
Bharadwaj S, Liu G, Shi Y, Markert C, Andersson KE, Atala A, Zhang Y. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering. Tissue Eng Part A. 2011 Aug; 17(15-16):2123-32.
Score: 0.006
-
Mangera A, Andersson KE, Apostolidis A, Chapple C, Dasgupta P, Giannantoni A, Gravas S, Madersbacher S. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol. 2011 Oct; 60(4):784-95.
Score: 0.006
-
Hennenberg M, Strittmatter F, Walther S, Hedlund P, Andersson KE, Stief CG, Schlenker B, Gratzke C. a1-adrenoceptor activation induces phosphorylation of ß2-adrenoceptors in human prostate tissue. BJU Int. 2011 Sep; 108(6):922-8.
Score: 0.006
-
Bauer RM, Strittmatter F, Gratzke C, Göttinger J, Schlenker B, Reich O, Stief CG, Hedlund P, Andersson KE, Hennenberg M. Coupling of a1-adrenoceptors to ERK1/2 in the human prostate. Urol Int. 2011; 86(4):427-33.
Score: 0.006
-
Nielsen JS, Rode F, Rahbek M, Andersson KE, Rønn LC, Bouchelouche K, Nordling J, Bouchelouche P. Effect of the SK/IK channel modulator 4,5-dichloro-1,3-diethyl-1,3-dihydro-benzoimidazol-2-one (NS4591) on contractile force in rat, pig and human detrusor smooth muscle. BJU Int. 2011 Sep; 108(5):771-7.
Score: 0.006
-
Abdel-Hamid IA, Andersson KE, Salonia A. Exploration of therapeutic targets for sexual dysfunctions: lessons learned from the failed stories. Expert Opin Ther Targets. 2011 Mar; 15(3):325-40.
Score: 0.006
-
Strittmatter F, Gratzke C, Weinhold P, Steib CJ, Hartmann AC, Schlenker B, Andersson KE, Hedlund P, Stief CG, Hennenberg M. Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms. Eur J Pharmacol. 2011 Jan 15; 650(2-3):650-5.
Score: 0.006
-
Burnett AL, Goldstein I, Andersson KE, Argiolas A, Christ G, Park K, Xin ZC. Future sexual medicine physiological treatment targets. J Sex Med. 2010 Oct; 7(10):3269-304.
Score: 0.006
-
Jin LH, Andersson KE, Kwon YH, Yoon SM, Lee T. Selection of a control rat for conscious spontaneous hypertensive rats in studies of detrusor overactivity on the basis of measurement of intra-abdominal pressures. Neurourol Urodyn. 2010 Sep; 29(7):1338-43.
Score: 0.006
-
Zhao W, Aboushwareb T, Turner C, Mathis C, Bennett C, Sonntag WE, Andersson KE, Christ G. Impaired bladder function in aging male rats. J Urol. 2010 Jul; 184(1):378-85.
Score: 0.006
-
Weinhold P, Gratzke C, Streng T, Stief C, Andersson KE, Hedlund P. TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation. J Urol. 2010 May; 183(5):2070-6.
Score: 0.006
-
Gratzke C, Angulo J, Chitaley K, Dai YT, Kim NN, Paick JS, Simonsen U, Uckert S, Wespes E, Andersson KE, Lue TF, Stief CG. Anatomy, physiology, and pathophysiology of erectile dysfunction. J Sex Med. 2010 Jan; 7(1 Pt 2):445-75.
Score: 0.006
-
Gratzke C, Weinhold P, Reich O, Seitz M, Schlenker B, Stief CG, Andersson KE, Hedlund P. Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells. Eur Urol. 2010 May; 57(5):902-10.
Score: 0.006
-
Zhao W, Sato Y, Melman A, Andersson KE, Christ G. Metrics for evaluation of age-related changes in erectile capacity in a rodent model. J Sex Med. 2009 Jul; 6(7):1885-92.
Score: 0.005
-
Ekman M, Andersson KE, Arner A. Receptor-induced phasic activity of newborn mouse bladders is inhibited by protein kinase C and involves T-type Ca2+ channels. BJU Int. 2009 Sep; 104(5):690-7.
Score: 0.005
-
Gratzke C, Christ GJ, Stief CG, Andersson KE, Hedlund P. Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. Eur Urol. 2010 Feb; 57(2):342-8.
Score: 0.005
-
Jin LH, Andersson KE, Kwon YH, Park CS, Yoon SM, Lee T. Substantial detrusor overactivity in conscious spontaneously hypertensive rats with hyperactive behaviour. Scand J Urol Nephrol. 2009; 43(1):3-7.
Score: 0.005
-
Aboushwareb T, Zhou G, Deng FM, Turner C, Andersson KE, Tar M, Zhao W, Melman A, D'Agostino R, Sun TT, Christ GJ. Alterations in bladder function associated with urothelial defects in uroplakin II and IIIa knockout mice. Neurourol Urodyn. 2009; 28(8):1028-33.
Score: 0.005
-
Christ GJ, Andersson KE, Williams K, Zhao W, D'Agostino R, Kaplan J, Aboushwareb T, Yoo J, Calenda G, Davies KP, Sellers RS, Melman A. Smooth-muscle-specific gene transfer with the human maxi-k channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys. Eur Urol. 2009 Dec; 56(6):1055-66.
Score: 0.005
-
Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, Atala A. Urine derived cells are a potential source for urological tissue reconstruction. J Urol. 2008 Nov; 180(5):2226-33.
Score: 0.005
-
Ekman M, Andersson KE, Arner A. Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder. BJU Int. 2009 Jan; 103(1):90-7.
Score: 0.005
-
Delo DM, Eberli D, Williams JK, Andersson KE, Atala A, Soker S. Angiogenic gene modification of skeletal muscle cells to compensate for ageing-induced decline in bioengineered functional muscle tissue. BJU Int. 2008 Sep; 102(7):878-84.
Score: 0.005
-
Gratzke C, Streng T, Waldkirch E, Sigl K, Stief C, Andersson KE, Hedlund P. Transient receptor potential A1 (TRPA1) activity in the human urethra--evidence for a functional role for TRPA1 in the outflow region. Eur Urol. 2009 Mar; 55(3):696-704.
Score: 0.005
-
Hodges SJ, Zhou G, Deng FM, Aboushwareb T, Turner C, Andersson KE, Santago P, Case D, Sun TT, Christ GJ. Voiding pattern analysis as a surrogate for cystometric evaluation in uroplakin II knockout mice. J Urol. 2008 May; 179(5):2046-51.
Score: 0.005
-
Lee T, Andersson KE, Streng T, Hedlund P. Simultaneous registration of intraabdominal and intravesical pressures during cystometry in conscious rats--effects of bladder outlet obstruction and intravesical PGE2. Neurourol Urodyn. 2008; 27(1):88-95.
Score: 0.005
-
Lu B, Poirier C, Gaspar T, Gratzke C, Harrison W, Busija D, Matzuk MM, Andersson KE, Overbeek PA, Bishop CE. A mutation in the inner mitochondrial membrane peptidase 2-like gene (Immp2l) affects mitochondrial function and impairs fertility in mice. Biol Reprod. 2008 Apr; 78(4):601-10.
Score: 0.005
-
Hipp J, Andersson KE, Kwon TG, Kwak EK, Yoo J, Atala A. Microarray analysis of exstrophic human bladder smooth muscle. BJU Int. 2008 Jan; 101(1):100-5.
Score: 0.005
-
Bivalacqua TJ, Kendirci M, Champion HC, Hellstrom WJ, Andersson KE, Hedlund P. Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1alpha. BJU Int. 2007 Jun; 99(6):1488-94.
Score: 0.005
-
Christ G, Andersson KE, Atala A. The future of bladder research: molecular profiling, new drug targets, gene therapy, and tissue engineering. Curr Urol Rep. 2007 Mar; 8(2):95-9.
Score: 0.005
-
Waldkirch ES, Uckert S, Langnäse K, Richter K, Jonas U, Wolf G, Andersson KE, Stief CG, Hedlund P. Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue. Eur Urol. 2007 Aug; 52(2):495-501.
Score: 0.005
-
Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol. 2006 Dec; 50(6):1194-207; discussion 1207.
Score: 0.004
-
Lagou M, De Vente J, Kirkwood TB, Hedlund P, Andersson KE, Gillespie JI, Drake MJ. Location of interstitial cells and neurotransmitters in the mouse bladder. BJU Int. 2006 Jun; 97(6):1332-7.
Score: 0.004
-
Streng T, Hedlund P, Talo A, Andersson KE, Gillespie JI. Phasic non-micturition contractions in the bladder of the anaesthetized and awake rat. BJU Int. 2006 May; 97(5):1094-101.
Score: 0.004
-
Oelke M, Hedlund P, Albrecht K, Ellinghaus P, Stief CG, Jonas U, Andersson KE, Uckert S. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. Urology. 2006 May; 67(5):1111-6.
Score: 0.004
-
Ekman M, Andersson KE, Arner A. Developmental regulation of nerve and receptor mediated contractions of mammalian urinary bladder smooth muscle. Eur J Pharmacol. 2006 Feb 17; 532(1-2):99-106.
Score: 0.004
-
Waldkirch E, Uckert S, Yildirim H, Sohn M, Jonas U, Stief CG, Andersson KE, Hedlund P. Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries--immunohistochemical distribution and functional significance. World J Urol. 2005 Dec; 23(6):405-10.
Score: 0.004
-
Streng TK, Talo A, Andersson KE, Santti R. A dose-dependent dual effect of oestrogen on voiding in the male mouse? BJU Int. 2005 Nov; 96(7):1126-30.
Score: 0.004
-
Matsumoto K, Yoshida M, Andersson KE, Hedlund P. Effects in vitro and in vivo by apomorphine in the rat corpus cavernosum. Br J Pharmacol. 2005 Sep; 146(2):259-67.
Score: 0.004
-
Crescioli C, Morelli A, Adorini L, Ferruzzi P, Luconi M, Vannelli GB, Marini M, Gelmini S, Fibbi B, Donati S, Villari D, Forti G, Colli E, Andersson KE, Maggi M. Human bladder as a novel target for vitamin D receptor ligands. J Clin Endocrinol Metab. 2005 Feb; 90(2):962-72.
Score: 0.004
-
Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, Christ G, Hatzichristou D, Hirsch M, Kimoto Y, Lewis R, McKenna K, MacMahon C, Morales A, Mulcahy J, Padma-Nathan H, Pryor J, de Tejada IS, Shabsigh R, Wagner G. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004 Jul; 1(1):6-23.
Score: 0.004
-
Brioni JD, Moreland RB, Cowart M, Hsieh GC, Stewart AO, Hedlund P, Donnelly-Roberts DL, Nakane M, Lynch JJ, Kolasa T, Polakowski JS, Osinski MA, Marsh K, Andersson KE, Sullivan JP. Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats. Proc Natl Acad Sci U S A. 2004 Apr 27; 101(17):6758-63.
Score: 0.004
-
Uckert S, Hedlund P, Waldkirch E, Sohn M, Jonas U, Andersson KE, Stief CG. Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone. World J Urol. 2004 Oct; 22(4):261-6.
Score: 0.004
-
Nehra A, Steers WD, Althof SE, Andersson KE, Burnett AL, Costabile RA, Goldstein I, Kloner RA, Lue TF, Morales A, Rosen RC, Shabsigh R, Siroky MB, King L. Third International Conference on the Management of Erectile Dysfunction: Linking Pathophysiology and Therapeutic Response. J Urol. 2003 Aug; 170(2 Pt 2):S3-5.
Score: 0.004
-
Drake MJ, Hedlund P, Andersson KE, Brading AF, Hussain I, Fowler C, Landon DN. Morphology, phenotype and ultrastructure of fibroblastic cells from normal and neuropathic human detrusor: absence of myofibroblast characteristics. J Urol. 2003 Apr; 169(4):1573-6.
Score: 0.004
-
Staskin DR, Wein AJ, Andersson KE, Bauer SB, Blaivas JG, Burgio KL, Cardozo L, Chapple CR, Dmochowski RR, Gupta S, Mostwin JL, Ouslander JG, Weiss JP, King L. Overview consensus statement. Urology. 2002 Nov; 60(5 Suppl 1):1-6.
Score: 0.003
-
Küthe A, Montorsi F, Andersson KE, Stief CG. Phosphodiesterase inhibitors for the treatment of erectile dysfunction. Curr Opin Investig Drugs. 2002 Oct; 3(10):1489-95.
Score: 0.003